Discover

NXTC
NextCure, Inc.
4.27
25 x 4.25
1 x 4.41
bid
ask
-
0.13
2.95%
01:09 PM
timesize
Ytd-69.91%
1y-17.88%
4.26
day range
4.62
1.55
52 week range
15.74
Open4.30Prev Close4.40Low4.26High4.62Mkt Cap11.79M
Vol134.68KAvg Vol2.11MEPS-17.19P/E-0.26Forward P/E-0.66
Beta1.42Short Ratio1.89Inst. Own57.52%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg4.50200-d Avg9.561yr Est3.33
Income Statement
Operating Expenses10.11M
Research and Development Expense6.83M
Selling, General and Administrative Expense3.27M
Operating Income-10.10M
Net Income-9.80M
Net Income Common Stock-9.80M
Net Income Common Stock (USD)-9.80M
Consolidated Income-9.80M
Earnings per Basic Share-1.87
Earnings per Basic Share (USD)-1.87
Earnings per Diluted Share-1.87
Earning Before Interest & Taxes (EBIT)-9.80M
Earning Before Interest & Taxes (USD)-9.80M
Weighted Average Shares5.24M
Weighted Average Shares Diluted5.24M
Balance Sheet
Cash and Equivalents15.17M
Cash and Equivalents (USD)15.17M
Investments14.58M
Investments Current14.58M
Current Assets31.74M
Property, Plant & Equipment Net5.39M
Total Assets37.98M
Total Debt3.88M
Current Liabilities6.89M
Debt Non-Current3.88M
Total Liabilities11.26M
Accumulated Retained Earnings (Deficit)-445.78M
Accumulated Other Comprehensive Income-2.00K
Shareholders Equity26.72M
Shareholders Equity (USD)26.72M
Assets Non-Current6.24M
Total Debt (USD)3.88M
Liabilities Non-Current4.37M
Trade and Non-Trade Payables3.07M
Cash Flow
Depreciation, Amortization & Accretion437.00K
Net Cash Flow from Financing1.25M
Net Cash Flow / Change in Cash & Cash Equivalents-10.81M
Issuance (Purchase) of Equity Shares1.25M
Net Cash Flow from Investing1.30M
Net Cash Flow - Investment Acquisitions and Disposals1.30M
Net Cash Flow from Operations-13.36M
Share Based Compensation344.00K